Platelet survival in patients with prosthetic heart valves.
D001241:Aspirin / Q000627:therapeutic use*; D001772:Blood Cell Count; D001777:Blood Coagulation / Q000187:drug effects; D001780:Blood Coagulation Tests; D001792:Blood Platelets / Q000187:drug effects*; D002470:Cell Survival / Q000187:drug effects; D002860:Chromium Radioisotopes; D002986:Clinical Trials as Topic; D006350:Heart Valve Prosthesis / Q000009:adverse effects*; D006801:Humans; D010919:Placebos; D010973:Platelet Adhesiveness / Q000187:drug effects; D011517:Prothrombin Time; D013927:Thrombosis / Q000209:etiology* / Q000517:prevention & control; D014859:Warfarin / Q000627:therapeutic use*
D002860:Chromium Radioisotopes; D010919:Placebos; D014859:Warfarin; D001241:Aspirin